Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 19.95 billion. The enterprise value is 20.39 billion.

Market Cap	19.95B
Enterprise Value	20.39B

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	Jul 8, 2024

Share Statistics

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. has 1.61 billion shares outstanding. The number of shares has decreased by -3.27% in one year.

Shares Outstanding	1.61B
Shares Change (YoY)	-3.27%
Shares Change (QoQ)	+1.15%
Owned by Insiders (%)	51.60%
Owned by Institutions (%)	12.68%
Float	435.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	22.53
PS Ratio	5.22
PB Ratio	3.33
P/FCF Ratio	20.14
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-49.87
EV / Sales	5.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	20.58

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 44.31.

Current Ratio	2.38
Quick Ratio	1.15
Debt / Equity	44.31
Debt / EBITDA	n/a
Debt / FCF	2.71
Interest Coverage	-5.94

Financial Efficiency

Return on equity (ROE) is -6.45% and return on invested capital (ROIC) is -3.23%.

Return on Equity (ROE)	-6.45%
Return on Assets (ROA)	-2.88%
Return on Capital (ROIC)	-3.23%
Revenue Per Employee	2.60M
Profits Per Employee	-281,825
Employee Count	1,451
Asset Turnover	0.36
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.81% in the last 52 weeks. The beta is 0.37, so Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+6.81%
50-Day Moving Average	11.67
200-Day Moving Average	13.04
Relative Strength Index (RSI)	62.43
Average Volume (20 Days)	5,109,046

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. had revenue of CNY 3.77 billion and -408.93 million in losses. Loss per share was -0.26.

Revenue	3.77B
Gross Profit	374.76M
Operating Income	-481.03M
Pretax Income	-573.44M
Net Income	-408.93M
EBITDA	-318.77M
EBIT	-481.03M
Loss Per Share	-0.26

Balance Sheet

The company has 2.24 billion in cash and 2.69 billion in debt, giving a net cash position of -444.33 million or -0.28 per share.

Cash & Cash Equivalents	2.24B
Total Debt	2.69B
Net Cash	-444.33M
Net Cash Per Share	-0.28
Equity (Book Value)	6.07B
Book Value Per Share	3.73
Working Capital	4.26B

Cash Flow

In the last 12 months, operating cash flow was 1.60 billion and capital expenditures -604.61 million, giving a free cash flow of 990.64 million.

Operating Cash Flow	1.60B
Capital Expenditures	-604.61M
Free Cash Flow	990.64M
FCF Per Share	0.62

Margins

Gross margin is 9.94%, with operating and profit margins of -12.76% and -10.85%.

Gross Margin	9.94%
Operating Margin	-12.76%
Pretax Margin	-15.21%
Profit Margin	-10.85%
EBITDA Margin	-8.45%
EBIT Margin	-12.76%
FCF Margin	26.27%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.81%.

Dividend Per Share	0.10
Dividend Yield	0.81%
Dividend Growth (YoY)	-13.04%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.27%
Shareholder Yield	4.08%
Earnings Yield	-2.08%
FCF Yield	4.97%

Stock Splits

The last stock split was on July 11, 2022. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 11, 2022
Split Type	Forward
Split Ratio	1.3